Corpus ID: 35233448

[A case of glomerulopathy associated with the vascular endothelial growth factor inhibitor bevacizumab].

@article{Haruhara2014ACO,
  title={[A case of glomerulopathy associated with the vascular endothelial growth factor inhibitor bevacizumab].},
  author={K. Haruhara and N. Tsuboi and Masatsugu Nakao and Kentaro Koike and Akira Fukui and Y. Miyazaki and T. Kawamura and M. Ogura and T. Yokoo},
  journal={Nihon Jinzo Gakkai shi},
  year={2014},
  volume={56 5},
  pages={
          600-5
        }
}
The patient was a 73-year-old Japanese female diagnosed with stage IIIc primary peritoneal cancer. After undergoing total hysterectomy and bilateral oophorectomy, she received regimens consisting of paclitaxel (PTX) and carboplatin (CBDCA). She subsequently developed recurrence four years after the disease onset and was treated with PTX, CBDCA and the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Bev). Although clinical remission was maintained with the administration of Bev… Expand